Attenuation by dextromethorphan on the higher liability to morphine-induced reward, caused by prenatal exposure of morphine in rat offspring by Wu, Ling-Yi et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
Journal of Biomedical Science
Open Access Research
Attenuation by dextromethorphan on the higher liability to 
morphine-induced reward, caused by prenatal exposure of 
morphine in rat offspring
Ling-Yi Wu†2, Jain-Fang Chen†1, Pao-Luh Tao*1 and Eagle Yi-Kung Huang*1
Address: 1Department of Pharmacology, National Defense Medical Center, Taipei, Taiwan and 2Division of Endocrinology and Metabolism, 
Department of Internal Medicine, Tri-Service General Hospital, Nei-Hu, Taipei, Taiwan
Email: Ling-Yi Wu - lingyiwukimo@yahoo.com.tw; Jain-Fang Chen - zolpidem@mail.cnpc.gov.tw; Pao-
Luh Tao* - pltao@mail.ndmctsgh.edu.tw; Eagle Yi-Kung Huang* - eyh58@mail.ndmctsgh.edu.tw
* Corresponding authors    †Equal contributors
Abstract
Co-administration of dextromethorphan (DM) with morphine during pregnancy and throughout
lactation has been found to reduce morphine physical dependence and tolerance in rat offspring.
No evidence was presented, however, for the effect of DM co-administered with morphine during
pregnancy on morphine-induced reward and behavioral sensitization (possibly related to the
potential to induce morphine addiction) in morphine-exposed offspring. Conditioned place
preference and locomotor activity tests revealed that the p60 male offspring of chronic morphine-
treated female rats were more vulnerable to morphine-induced reward and behavioral
sensitization. The administration of a low dose of morphine (1 mg/kg, i.p.) in these male offspring
also increased the dopamine and serotonin turnover rates in the nucleus accumbens, which implied
that they were more sensitive to morphine. Co-administration of DM with morphine in the dams
prevented this adverse effect of morphine in the offspring rats. Thus, DM may possibly have a great
potential in the prevention of higher vulnerability to psychological dependence of morphine in the
offspring of morphine-addicted mothers.
Background
Growth retardation, delayed motor development and
behavior abnormalities have been proposed in offspring
of heroin-addicted mothers [1]. Infants passively exposed
to morphine through their addicted mothers easily devel-
oped morphine withdrawal syndrome after birth, whom
even needed intensive care [2-4]. In our previous studies,
we observed that many adverse effects caused by prenatal
exposure of morphine could be prevented by the co-
administration of dextromethorphan (DM) in morphine-
dependent rat dams [5,6]. However, the possible impacts
of prenatal exposure of morphine on the vulnerability to
drug addiction have seldom been examined. In humans,
the liability to opioid dependence can be affected by
acquired physical conditions and social factors in off-
spring from morphine-addicted mother. Thus, we
attempted to investigate the possible effects of prenatal
exposure to morphine on the vulnerability to morphine-
induced reward in an animal model of rats. In addition,
the possible protective effect of the co-administered DM
was also tested.
Being a non-competitive antagonist at the glutamatergic
N-methyl-D-aspartate (NMDA) receptors, DM was
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thought to exert many of its pharmacological actions
through the blockade of NMDA receptor [7], although
DM was reported to act at the other targets (e.g. nicotinic
α3β4 receptors and sigma receptors) as well [8,9]. Activa-
tion of the NMDA receptors has been implicated in the
regulation of reward-related mesolimbic pathway in
many reports [10-12]. Therefore, we speculated that the
prenatal administration of morphine and DM to the dams
may affect the development of the neural systems which
will be functionally correlated with opioid-induced
reward in the offspring. In order to investigate the liability
to morphine-induced reward, we used conditioned place
preference (CPP) test to perform quantitative verification
of morphine-induced reward. The CPP tests were carried
out on the rats which were the offspring from the mor-
phine-dependent dams. The possible effect of prenatal
exposure of morphine and DM on behavioral sensitiza-
tion was also examined in the locomotor activity test.
Using HPLC, the dopamine and the serotonin turnover
rates were determined in the terminal regions of mesolim-
bic pathway to correlate with the results from behavioral
experiments.
Materials and methods
Animals
Adult female Sprague-Dawley rats were purchased from
the National Experimental Animal Centre, Taipei, Taiwan.
The animals were housed two in a cage, in a room main-
tained at a temperature of 23 ± 2°C with a 12 h light-dark
cycle. Food and water were available ad libitum through-
out the experiment. Rats were randomly separated into
four groups. Rats received subcutaneous (s.c.) injection of
saline (control group), morphine (M group), morphine +
dextromethorphan (M + DM group) and dextromethor-
phan (DM group) twice per day (9 AM and 5 PM) and
progressively increased with 1 mg/kg at 7-day intervals
from a beginning dose of 2 mg/kg for both morphine and
dextromethorphan. The rats were mated on day 8 and the
drug administration was continued during pregnancy.
After rat offspring were born, the injections of drugs into
the dams were stopped. Male offspring rats of four groups
(60 days after delivery) were used for CPP test and loco-
motor activity test. The care of animals was carried out in
accordance with institutional and international standards
(Principles of Laboratory Animal Care, National Institutes
of Health), and the protocol was approved by the Institu-
tional Animal Care and Use Committee of National
Defense Medical Center, Taiwan, R.O.C.
Schedule of drug administration for CPP test and 
locomotor activity test
As shown in Fig. 1A, a 7-day schedule was employed for
the CPP tests. One day before the start of the experiments,
the animals were placed in an isolated dark room for 60
min for habituation. On day 0, pre-drug place preference
was tested in the dark room. CPP conditionings and drug
injections [morphine (1 mg/kg, i.p.)/saline] were per-
formed from day 1 to day 5, alternating saline injection
(i.p.) in the morning with morphine injection (i.p.) in the
afternoon. Post-drug place preference was measured and
recorded on day 6.
In another set of experiments, the total time of the sched-
ule for drug administration and locomotor activity tests
was 10 days (Fig. 1B). Drug administration [morphine (1
mg/kg, i.p.)] was conducted on day 0, 1, 2, 3, 4, 5, 6 and
10. One day before the start of the experiments, the ani-
mals were brought to the room and placed in the test
cages for 60 min to allow them to adapt to the environ-
ment for locomotor activity test. Following injection of
the drugs, the rats were immediately put into the cages for
locomotor activity determination on day 0, 6, and 10.
Conditioned place preference (CPP) test
The CPP apparatus, made from an acrylic plastic box (70
× 25 × 25 cm), was divided into three compartments. Two
identically sized compartments (30 × 25 × 25 cm) were
constructed at both sides, separated by a narrower com-
partment (10 × 25 × 25 cm). The compartments were con-
nected by guillotine doors (10 × 10 cm) in the central
unit. One of the large compartments was covered by
mosaic type paper (2.5 × 2.5 cm black and white squares)
on the three walls and floor, as a visual cue; the other large
compartment was covered by purely white paper. To give
more visual cues, a blue and a red light bulb were hung
separately above the two large compartments. During the
experiments, the CPP apparatus was kept in an isolated
dark room, which was free from noise. After each behav-
ioral test or place conditioning, the whole box was
cleaned thoroughly to prevent interference from the smell
of feces and urine. The animals were handled (30 min per
day) for at least 3 days prior to the experiments. In this
non-biased-design CPP apparatus, the rats were first
placed into the central compartment. Their initial (pre-
drug) place preference was determined by giving them
free access to the entire box for 15 min. During the follow-
ing 5 days, the rats were drug-conditioned for 5 times and
saline-conditioned for 5 times. The animals were kept for
40 min in the corresponding compartment with the guil-
lotine doors closed. Giving morphine in the morning and
saline in the afternoon, these place conditionings were
carried out to ensure the visual cue association for each
rat. Post-drug place preference was examined on day 6.
The test time was also 15 min.
Locomotor activity test
The ambulatory and the total activity of rats were meas-
ured in transparent standard polypropylene animal cages
(38 × 22 × 15 cm). The test cages were placed in a photo
beam activity system (San Diego Instruments, U.S.A.). AJournal of Biomedical Science 2009, 16:106 http://www.jbiomedsci.com/content/16/1/106
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computer control unit registered the interruption of pho-
tobeams from five individual cages. Ambulatory activity
was recorded as breaks of two consecutive beams, whereas
breaks of a single photobeam were determined as total
activity. Activity was recorded in 5-min periods for 1 hour
immediately after drug or saline administration. The
experiments of locomotor activity were performed in an
isolated noise-free room. The total and ambulatory activ-
ities recorded were both normalized as the percentage of
the activity obtained on day 0 (as shown in Fig. 1B).
High performance liquid chromatography (HPLC) analysis 
of dopamine and serotonin metabolites
Adult male rats (8 to 10 weeks old) from four groups were
sacrificed by decapitation 30 min after a challenge of mor-
phine injection (1 mg/kg, i.p.). The whole brain was
placed in an acrylic brain matrix (1 mm section coronal,
Braintree Scientific, U.S.A.). Using a sharp blade, one
third of the full length of brain (without the olfactory
bulbs and the cerebellum) was vertically cut off from the
rostral side. A coronal slice of 1 mm was obtained by slic-
ing at the adjacent indent of the matrix. Co-ordinating
with the anterior commissure as a landmark, the neucleus
accumbens (NAc) was carefully cut away from the stria-
tum with a forceps, and the striatum was separated into
A: Time schedule of the CPP test Figure 1
A: Time schedule of the CPP test. B: Time schedule of the locomotor activity test.Journal of Biomedical Science 2009, 16:106 http://www.jbiomedsci.com/content/16/1/106
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dorsal and ventral portions with a horizontal cut. Follow-
ing removal of the olfactory bulb, the olfactory tubercles
(OT) was also carefully dissected. The medial prefrontal
cortex (mPFC) was obtained from the previous slice,
which was the horizontal layer above the NAc site. Tissues
were homogenized in 1 mM of oxalic acid. The samples
were centrifuged (4,300 g, 20 min) and filtered through
an Acrodisc 25-mm syringe filter with 0.2-μm super mem-
brane (PN: 4612, PALL Life Sciences, U.S.A.). The filtered
samples were injected into the high performance liquid
chromatography (HPLC) system for measurement of
dopamine (DA), serotonin (5-HT), and their metabolites
[dopamine metabolites: 3,4-dihydroxyphenylacetic acid
(DOPAC) and homovanillic acid (HVA); serotonin
metabolite: 5-hydroxyindole acetic acid (5-HIAA)]. The
DA and 5-HT turnover rates were calculated to provide a
better indication of their neuronal activity. The DA turno-
ver rate was calculated as ([DOPAC] + [HVA])/[DA], while
the 5-HT turnover rate was calculated as [5-HIAA]/[5-HT].
Using linear regression, standard curves were constructed,
which covered a wide range of concentrations (10-1,000
nM). The samples were compared with the standard curve
to determine their contents of DOPAC, HVA, DA, 5-HIAA,
and 5-HT. The electrochemical chromatographic system
consisted of a pump (LC-10AD, Shimadzu, Japan), a
TSKgel ODS-80TM C18 column (Tosoh, Japan), and an
electrochemical detector (Coulochem II, ESA, Chelms-
ford, MA, U.S.A.) containing a 5020 guard cell and 5010
analytical cells. The voltage of guard cell (mobile phase
cell) was set at 350 mV. The analytical cells were set at 40
and 250 mV (detecting potential). The mobile phase
(MDTM mobile phase, ESA) consisted of 75 mM sodium
dehydrogenate phosphate (monohydrate), 1.7 mM 1-
octanesulfonic acid (sodium salt), 100 μl/L triethylamine,
25 μM EDTA, 10% acetonitrile, pH 3.00, which was deliv-
ered at a flow rate of 1.0 ml/min.
Statistical analysis
The data were all expressed as means ± SEM. One-way
ANOVA followed by Newman-Keuls test was employed to
examine the statistical significance of the difference
between groups. In the tests of locomotor activity, one-
way ANOVA followed by Newman-Keuls test was also
used to examine the significance of the difference from the
activity recorded on day 0. In the CPP tests, paired t-test
was employed to examine the difference in the same ani-
mal before and after drug administration. P < 0.05 was
considered statistically significant.
Materials
Morphine hydrochloride was purchased from the
National Bureau of Controlled Drugs, National Health
Administration, Taipei, Taiwan, R.O.C. Dextromethor-
phan and all other chemicals were purchased from Sigma
(St. Louis, MO, USA). The chemicals were all of analytical
grade, and the solvents were of HPLC grade.
Results
Chronic morphine administration of the dams caused a 
more sensitive response to reward of morphine in the 
offspring rats, which could be prevented by the co-
administration of DM in the dams
As shown in Fig. 2, the time spent in the drug-associated
compartment minus the time spent in the saline-associ-
ated compartment was expressed as place preference
induced by drugs. Before conditioning (day 0), p60 rats of
the control group showed no significant place preference
(32 ± 47.6 sec) for the drug-associated compartment,
which indicated that the CPP apparatus that we used was
of a non-biased design [13]. After five times of low dose of
morphine (1 mg/kg, i.p.) conditionings, the rats of the
control group still showed no significant place preference
(-44.6 ± 82.7 sec). However, rats of the morphine group
showed a significant place preference for the morphine-
associated compartment (from -44.5 ± 28.3 sec increased
to 151.3 ± 49.3 sec) (p < 0.01) after conditionings. This
indicated that morphine caused a significant reward in the
rat offspring of the morphine group. In the DM group, the
animals exhibited no place preference in response to low
dose morphine conditionings (day 0: 69.8 ± 25.6 sec vs.
day 6: 18.3 ± 55 sec). In the M + DM group, the animals
also showed no place preference on both day 0 (-9.7 ±
52.8 sec) and day 6 (-93.8 ± 90 sec) (Fig. 2). This sug-
gested that the co-administration of DM with morphine
in the dams could effectively reduce the response to mor-
phine-induced reward in the offspring rats.
Chronic morphine administration of the dams caused a 
more sensitive response to morphine-induced behavioral 
sensitization in the offspring rats, which could be 
prevented by the co-administration of DM in the dams
For the total locomotor activity in 2 hours after injection
of morphine (1 mg/kg) (Fig. 3), the rat offspring (p60) of
the control group showed no significant difference among
the activities recorded on day 0, day 6, and day 10. In the
morphine group, the rat offspring showed a significant
increase in the total locomotor activity on day 6 and day
10 when compared with the activity on day 0 after injec-
tion of morphine (1 mg/kg) (day 6: 238.6 ± 82.3% of day
0 activity, p < 0.001; day 10: 257.0 ± 64.8% of day 0 activ-
ity, p < 0.01). In the M + DM and the DM group, there was
no significant difference among the activities recorded on
day 0, day 6, and day 10 after injection of morphine (1
mg/kg) (Fig. 3). As shown in Fig. 4, the results of the
ambulatory locomotor activity displayed a similar pattern
to that of the total locomotor activity. These results indi-
cated that chronic morphine administration of the dams
caused a more sensitive response to morphine-inducedJournal of Biomedical Science 2009, 16:106 http://www.jbiomedsci.com/content/16/1/106
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behavioral sensitization in the offspring rats, which could
be prevented by the co-administration of DM in the dams.
Morphine-induced neurochemical change of dopamine 
and serotonin turnover rates in various brain regions 
obtained from the offspring of the morphine/DM/
(morphine + DM)-treated dams
As shown in Fig. 5(A), offspring rats of the morphine
group showed a higher dopamine turnover rate [1.29 ±
0.06 (morphine group) vs. 0.95 ± 0.11 (control group); p
Effect of morphine (1 mg/kg) to induce rewarding in the male offspring rats (p60) from different groups, which was measured  by conditioned place preference (CPP) tests (A: Control group; B: Morphine group; C: M + DM group; D: DM group) Figure 2
Effect of morphine (1 mg/kg) to induce rewarding in the male offspring rats (p60) from different groups, which 
was measured by conditioned place preference (CPP) tests (A: Control group; B: Morphine group; C: M + DM 
group; D: DM group). Data were expressed as preference for the drug-paired compartment, which was determined by time 
spent in the drug-paired compartment minus time spent in the saline-paired compartment. Data were presented as mean ± 
SEM., and paired t-test was used to analyze the data (**p < 0.01 for day 6 vs. day 0; n  8).Journal of Biomedical Science 2009, 16:106 http://www.jbiomedsci.com/content/16/1/106
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< 0.05] in the NAc in response to an acute morphine chal-
lenge (1 mg/kg, i.p.). However there was no significant
difference in the dorsal striatum (DS), medial prefrontal
cortex (mPFC), and olfactory tubercle (OT) among differ-
ent groups. In the M + DM group, the dopamine turnover
rate in the NAc was not significantly different from the
rates of the control group [0.96 ± 0.04 (M + DM group) vs.
0.95 ± 0.11 (control group)]. The dopamine turnover rate
in the NAc of the animals from M + DM group was signif-
icantly lower when compared with that of the M group
[0.96 ± 0.04 (M + DM group) vs. 1.29 ± 0.06 (morphine
group); p < 0.05]. Consistent with the results of DA turn-
over rate, offspring rats of the morphine group showed a
higher serotonin turnover rate [2.68 ± 0.05 (morphine
group) vs. 1.15 ± 0.27 (control group); p < 0.05] in the
NAc in response to an acute morphine challenge (1 mg/
Effects of morphine (1 mg/kg) on behavioral sensitization of total locomotor activity in the male offspring rats (p60) from differ- ent groups (A: Control group; B: Morphine group; C: M + DM group; D: DM group) Figure 3
Effects of morphine (1 mg/kg) on behavioral sensitization of total locomotor activity in the male offspring rats 
(p60) from different groups (A: Control group; B: Morphine group; C: M + DM group; D: DM group). Data were 
presented as mean ± SEM. Student t-test was used to analyze the data for the significance of the difference from the activity on 
day 0 (**p < 0.01, ***p < 0.001 compared with the data on day 0; n  7).Journal of Biomedical Science 2009, 16:106 http://www.jbiomedsci.com/content/16/1/106
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kg, i.p.) (Fig. 6). No significant difference was observed in
the DS, PFC, and OT among different groups either. In the
M + DM group, the serotonin turnover rate in the NAc was
also not significantly different from the rates of the con-
trol group [1.10 ± 0.24 (M + DM group) vs. 1.15 ± 0.27
(control group)]. The serotonin turnover rate in the NAc
of the animals from M + DM group was significantly lower
when compared with that of the M group [1.10 ± 0.24 (M
+ DM group) vs. 2.68 ± 0.05 (morphine group); p < 0.05].
These results suggested that the mesolimbic dopaminergic
system and serotoninergic system of the offspring from
the dams with previous chronic morphine exposure was
more sensitive to morphine, but this effect could be pre-
vented by the co-administration of DM with morphine in
the dams.
Effects of morphine (1 mg/kg) on behavioral sensitization of ambulatory locomotor activity in the male offspring rats (p60) from  different groups (A: Control group; B: Morphine group; C: M + DM group; D: DM group) Figure 4
Effects of morphine (1 mg/kg) on behavioral sensitization of ambulatory locomotor activity in the male off-
spring rats (p60) from different groups (A: Control group; B: Morphine group; C: M + DM group; D: DM 
group). Data were presented as mean ± SEM. Student t-test was used to analyze the data for the significance of the difference 
from the activity on day 0 (*p < 0.05 compared with the data on day 0; n  7).Journal of Biomedical Science 2009, 16:106 http://www.jbiomedsci.com/content/16/1/106
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Discussion
Previously, we found that the co-administration of dex-
tromethorphan with morphine to dam rats throughout
pregnancy significantly decreased morphine-induced
physical dependence and tolerance in their offspring [5].
In correlation with morphine dependence, we investi-
gated the possible effect of maternal morphine adminis-
tration on morphine-induced reward in the CPP tests in
the present study. Using a low dose of morphine (1 mg/
kg, i.p.) in conditionings, the offspring from morphine-
treated dams showed a significant place preference for
morphine-paired compartment, but the offspring from
the other groups, including control group, showed no
place preference. This suggests that the offspring from
morphine-addicted mother could be more sensitive to
morphine-induced reward. That is to say, they could be
more vulnerable to morphine dependence and easier to
become addicted to morphine after first postnatal mor-
phine exposure. Maternal co-administration of DM with
morphine also abolished the effect of morphine on the
Effects of morphine (1 mg/kg) on the dopamine turnover rate ([DOPAC+HVA]/[DA]) of the male offspring rats (p60) from dif- ferent groups in the (A) nucleus accumbens (NAc), (B) dorsal striatum (DS), (C) medial prefrontal cortex (mPFC), and (D)  olfactory tubercle (OT) Figure 5
Effects of morphine (1 mg/kg) on the dopamine turnover rate ([DOPAC+HVA]/[DA]) of the male offspring 
rats (p60) from different groups in the (A) nucleus accumbens (NAc), (B) dorsal striatum (DS), (C) medial 
prefrontal cortex (mPFC), and (D) olfactory tubercle (OT). Data were presented as means ± SEM. One-way ANOVA 
followed by Newman-Keuls test was used to analyze the data (*p < 0.05 for the morphine group vs. the control group; #p < 
0.05 for the M + DM group vs. the morphine group; n  6).Journal of Biomedical Science 2009, 16:106 http://www.jbiomedsci.com/content/16/1/106
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CPP in the offspring. In 1997, Gagin et al. first demon-
strated that prenatal morphine exposure (gestational days
12-18) enhances morphine-induced CPP in adult rats
[14]. Our results were consistent with the finding by
Gagin et al., but the morphine administration was
throughout the pregnancy in our protocol. A recent report
by Riley and Vathy showed that mid- to late gestational
morphine exposure did not alter the rewarding properties
of morphine in adult male rats [15]. In this study, they
used many doses of morphine in conditionings of their
CPP paradigm. Because the dose-dependent CPP of mor-
phine was not observed, they interpreted their data as no
effect of prenatal morphine exposure. In fact, only the off-
spring from morphine-treated mother showed a possibly
significant CPP by morphine after low dose (0.1 mg/kg,
s.c.) of morphine conditionings in their study, whereas
the other groups of rats did not respond to this dose of
morphine. To compare with our results, the controversial
different conclusions between ours and the one from
Riley and Vathy could be due to the sensitivity of CPP par-
Effects of morphine (1 mg/kg) on the dopamine turnover rate ([5-HIAA]/[5-HT]) of the male offspring rats (p60) from different  groups in the (A) nucleus accumbens (NAc), (B) dorsal striatum (DS), (C) medial prefrontal cortex (mPFC), and (D) olfactory  tubercle (OT) Figure 6
Effects of morphine (1 mg/kg) on the dopamine turnover rate ([5-HIAA]/[5-HT]) of the male offspring rats 
(p60) from different groups in the (A) nucleus accumbens (NAc), (B) dorsal striatum (DS), (C) medial prefron-
tal cortex (mPFC), and (D) olfactory tubercle (OT). Data were presented as means ± SEM. One-way ANOVA followed 
by Newman-Keuls test was used to analyze the data (*p < 0.05 for the morphine group vs. the control group; #p < 0.05 for the 
M + DM group vs. the morphine group; n  5).Journal of Biomedical Science 2009, 16:106 http://www.jbiomedsci.com/content/16/1/106
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adigm and the selection of marginal doses of morphine to
induce CPP.
In order to provide the neurochemical evidence, we inves-
tigated the change of dopamine and serotonin turnover at
the terminals of mesocorticolimbic pathway in response
to low dose (1 mg/kg) of morphine. The present results
showed that mesocorticolimbic system of rat offspring of
morphine group was more sensitive to morphine, but the
rat offspring received the co-administration of DM with
morphine did not show this effect. Interestingly, the ele-
vated dopamine turnover rate caused by prenatal mor-
phine was only observed at the NAc, but not mPFC. Since
we used a marginal low dose of morphine to induce
reward, the mesolimbic pathway, originating from VTA
and terminating at NAc, could be more sensitive in
response to morphine, when compared with the mesocor-
tical pathway. Although the mechanism of DM to reduce
the sensitivity of mesocorticolimbic system was still
unknown, these neurochemical data supported the find-
ing of behavioral experiments and further highlighted the
possible therapeutic potential of DM. In addition to CPP,
we examined another behavioral parameter, behavioral
sensitization of locomotor activity, which has been
viewed as an important factor in the development and
maintenance of addiction. Repeated administration of
morphine results in augmentation of locomotor and/or
stereotype behaviors [16-18]. The phenomenon could
persist for a long period after morphine withdrawal and
was called as "behavioral sensitization" [19]. This behav-
ior was also presumed to be caused by the sensitization of
mesolimbic dopaminergic pathway [20,21]. Our results
of behavioral sensitization showed exactly the same pat-
tern as those tested in the CPP experiments. This recon-
firmed the effect of prenatal morphine exposure to cause
a more sensitized mesolimbic pathway, and the effect of
co-administered DM to decrease the prenatal impact of
morphine in the offspring.
In our neurochemical results of 5-HT, we found that the
serotoninergic projections to NAc were also more sensi-
tive to morphine stimulation to release 5-HT in offspring
from morphine-treated dams. Although the role of 5-HT
was traditionally thought to be one of the neuro-sub-
strates in producing reward, a recent report by Weitemier
and Murphy confirmed that serotoninergic and dopamin-
ergic systems at the NAc play modulatory roles in concert
for morphine-induced place preference [22]. Interest-
ingly, the only brain region where we observed significant
differences for 5-HT and DA turnover was both at the NAc.
Although the mPFC and OT were also known as the termi-
nals of mesolimbocortical pathways, the NAc was most
relevant and may directly link to the induction of reward.
The data at the DS was found to be with no difference
between groups, which may serve as the negative control
to verify our neurochemical analysis. Anyhow, the release
of 5-HT at NAc was more sensitive in response to mor-
phine in the offspring from morphine-treated dams,
which may also contribute to the higher liability to mor-
phine-induced reward.
Regarding to the mechanism of DM to reduce the adverse
effects of prenatal morphine, many behavioral studies
revealed that NMDA receptors are involved in the devel-
opment of rewarding effect related to psychological
dependence caused by chronic morphine exposure
[23,24]. In our previous study, we also showed that the
co-administration of ifenprodil (a selective NR2B subu-
nit-containing NMDA receptor antagonist) with mor-
phine at the NAc, not at the VTA, could reduce morphine
rewarding and drug-seeking effect, but not behavioral sen-
sitization [25]. Another report demonstrated that the
NMDA receptor antagonists: dizocilpine and ketamine,
which have similar affinity for NR2A and NR2B subunit-
containing NMDA receptors, suppress morphine-induced
rewarding effect [26]. These results suggest that the NR2B
subunit-containing NMDA receptor in the NAc may be
associated with the rewarding effect of morphine. There-
fore, DM may possibly act through the blockade of NMDA
receptors to affect morphine-induced reward in offspring
from morphine-treated dams, although there was no
direct evidence showing the link between the prenatal
blockade of NMDA receptors and the increased sensitivity
of mesolimbic dopaminergic pathway in the literatures.
Since the blockade of NMDA receptors could be able to
affect numbers of various protein expressions during pre-
natal stage, the possibility of increased or decreased func-
tional proteins (e.g. receptors, transporters etc.) should be
taken into account for the cause of sensitized mesolimbic
system in adulthood. During development, the neural
change could be complicated and the relevant mecha-
nisms of prenatal DM remain to be tested in further inves-
tigations.
In summary, the present study provides behavioral and
neurochemical evidences in neonatal rats passively
exposed to morphine throughout embryo stages, which
suggest that they could be easier to develop many adverse
effects, possibly including psychological dependence of
morphine. Therapeutically, DM could reverse these
adverse effects caused by prenatal morphine. The current
results implied the possible biological change in offspring
from morphine-addicted mother in humans. Moreover,
the therapeutic potential of DM was further highlighted;
especially our previous report also indicated the ability of
DM to reduce morphine-induced hyperprolactinemia in
female rats at different reproductive stages [27].
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